Blog Full Right Sidebar

Zydus Lifesciences said it has received final approval from the US health regulator to manufacture a generic version of Apalutamide tablets used in the treatment of prostate cancerRead More

Analysts expect the market recovery to continue in the near term on the back of positive global cues and value buying at lower levels.Read More

The NSE Nifty surged 325.55 points, or 1.45%, to close at 22,834.30. The BSE Sensex rose 1131.31 points, or 1.53%, to end at 75,301.26. Both indices have risen about 2% in the last two days.Read More

IndusInd Bank promoters reaffirm their commitment to the bank, viewing its depressed stock value as a strategic investment opportunity. Despite a 50% drop in six months, no fresh capital infusion is required. Hinduja Group holds a 16.29% stake, with 50.8% pledged.Read More

Foreign Institutional Investors (FIIs) bought Indian equities worth ₹694.57 crore on Tuesday, their first net purchase since February 19. Along with Domestic Institutional Investors (DIIs) buying ₹2,534.75 crore, this institutional inflow boosted Nifty and Sensex, which closed with significant gains.Read More